Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
7
FDA:7
Drug Approvals
Clinical Trials
No trials found
News
Federal Circuit Reverses PTAB Decision on Brimonidine Eye Redness Patent in Landmark Claim Construction Ruling
The Federal Circuit reversed the Patent Trial and Appeal Board's claim construction of U.S. Patent No. 8,293,742, which covers methods for reducing eye redness using brimonidine as the sole active ingredient.